Possible Interactions Between Deprenyl and Prozac

O. Suchowersky; J. deVries

doi:10.1017/S0317167100030730

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

References

1. Settle, EC, Settle, GP. A case of mania associated with fluoxetine. Am J Psych 1984; 141: 280–281.Google Scholar PubMed

2. Lebeque, B. Mania precipitated by fluoxetine (letter). Am J Psych 1987; 144: 1620.Google Scholar

3. Menza, MA, Golbe, LI. Hypomania in a patient receiving deprenyl (selegiline) after adrenel-strialal implantation for Parkinson’s disease. Clin Neuropharm 1988; 5: 549–551.CrossRef Google Scholar

4. McGrath, PJ, Stewart, JW, Quithin, FM. A possible L-deprenyl induced hypertension reaction. J Psychopharm 1989; 9: 310–311.Google Scholar

5. Sternbach, H. Danger of MAOI therapy after fluoxetine withdrawal (letter). Lancet 1988; 2: 850–851.Google Scholar

Crossref Citations

This article has been cited by the following publications. This list is generated based on data provided by Crossref.

Heinonen, E. H. and Lammintausta, R. 1991. A review of the pharmacology of selegiline. Acta Neurologica Scandinavica, Vol. 84, Issue. S136, p. 44.

Jon Stoessl, A. 1992. Prevention and Management of Late Stage Complications in Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, Vol. 19, Issue. S1, p. 113.

Vezina, Paul Mohr, Erich and Grimes, David 1992. Deprenyl in Parkinson’s Disease: Mechanisms, Neuroprotective Effect, Indications and Adverse Effects. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, Vol. 19, Issue. S1, p. 142.

Cesura, Andrea M. and Pletscher, Alfred 1992. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. p. 171.

Heinonen, E. H. Anttila, M. I. and Lammintausta, R. A. S. 1993. Inhibitors of Monoamine Oxidase B. p. 201.

Montastruc, J.L. Chamontin, B. Senard, J.M. Tran, M.A. Rascol, O. Llau, M.E. and Rascol, A. 1993. Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline. The Lancet, Vol. 341, Issue. 8844, p. 555.

Ahlskog, J. Eric 1994. Treatment of Parkinson's disease. Postgraduate Medicine, Vol. 95, Issue. 5, p. 52.

Waters, C.H. 1994. Fluoxetine and Selegiline – Lack of Significant Interaction. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, Vol. 21, Issue. 3, p. 259.

Messer-Kremer, M Herrscher, M Schlienger, JL and Sagez, JF 1995. Pseudophéochromocytome chez un sujet parkinsonien traité par sélégiline. La Revue de Médecine Interne, Vol. 16, Issue. 3, p. 229.

Hilton, S. E. Maradit, H. and Möller, H. J. 1997. Serotonin syndrome and drug combinations: focus on MAOI and RIMA. European Archives of Psychiatry and Clinical Neuroscience, Vol. 247, Issue. 3, p. 113.

Danielczyk, W. 1999. Neuro-Psychopharmaka Ein Therapie-Handbuch. p. 316.

Zesiewicz, Theresa A. Gold, Michael Chari, Ganesh and Hauser, Robert A. 1999. Current Issues in Depression in Parkinson's Disease. The American Journal of Geriatric Psychiatry, Vol. 7, Issue. 2, p. 110.

Zesiewicz, Theresa A. and Hauser, Robert A. 2000. Depression in Patients with Parkinson??s Disease. CNS Drugs, Vol. 13, Issue. 4, p. 253.

Jacob, Jeena E Wagner, Mary L and Sage, Jacob I 2003. Safety of Selegiline with Cold Medications. Annals of Pharmacotherapy, Vol. 37, Issue. 3, p. 438.

Henchcliffe, Claire Schumacher, H Christian and Burgut, F Tuna 2005. Recent advances in Parkinson’s disease therapy: use of monoamine oxidase inhibitors. Expert Review of Neurotherapeutics, Vol. 5, Issue. 6, p. 811.

Juncos, Jorge L. 2006. Medical Management of the Surgical Patient. p. 430.

Rabey, Jose Martin 2007. Parkinson's Disease and Related Disorders, Part I. Vol. 83, Issue. , p. 435.

BRENT, JEFFREY and PALMER, ROBERT 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. p. 561.

Article contents

Possible Interactions Between Deprenyl and Prozac

Abstract

References

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests